Amanda Burnham-Marusich is the Director of Research and Development at DxDiscovery with expertise in monoclonal antibody production and immunoassay development (ELISA and lateral flow). Her research interests center on improving public health through better diagnosis of infectious disease, specifically identification of effective biomarkers for fungal or bacterial infection and the development of rapid, low-cost diagnostic immunoassays. Dr. Burnham-Marusich has been the Principal Investigator on over $8 million worth of Phase I, Phase II, and Phase IIB SBIR grants from NIH to develop immunoassay diagnostics. She earned her B.S. and M.S. in Biological Sciences from Stanford University and her Ph.D. in Cell and Molecular Biology from the University of Nevada, Reno. Her post-doctoral training was completed in the Diagnostics Discovery Laboratory at the University of Nevada, Reno School of Medicine.